1 Rafie IM, Colucci WS. Alcoholic cardiomyopathy. Dec 22 2016; Available from: UpToDate.
2 Ammash NM, Tajik AJ. Idiopathic restrictive cardiomyopathy. Jun 29, 2018; Available from: UpToDate.
3 Saglini V, Lazzaro M, Keller F, Perren A. [Detection of hereditary hemochromatosis]. Rev Med Suisse, 2007;3(123):1952–7.
4 Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS; American Association for the Study of Liver Diseases. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology, 2011;54(1):328–43.
5 Rombout-Sestrienkova E, van Kraaij MG, Koek GH. How we manage patients with hereditary haemochromatosis. Br J Haematol. 2016;175(5):759–70.
6 Bacon BR. Clinical manifestations and diagnosis of hereditary hemochromatosis. Sep 23 2018; Available from: UpToDate.
7 Kumar N, Rizek P, Sadikovic B, Adams PC, Jog M.Movement Disorders Associated With Hemochromatosis. Can J Neurol Sci. 2016;43(6):801–8.
8 Adams P, Altes A, Brissot P, Butzeck B, Cabantchik I, Cançado R, et al.; Contributors and Hemochromatosis International Taskforce. Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype. Hepatol Int. 2018;12(2):83–6.
9 Adams PC, Barton JC. How I treat hemochromatosis. Blood. 2010;116(3):317–25.
10 Cançado R, Melo MR, de Moraes Bastos R, Santos PC, Guerra-Shinohara EM, Chiattone C, Ballas SK.Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study. Eur J Haematol. 2015;95(6):545–50.
11 Bacon BR. Management of patients with hereditary hemochromatosis. Sep 13 2018; Available from: UpToDate.
12 Niederau C, Fischer R, Pürschel A, Stremmel W, Häussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996;110(4):1107–19.
13 Bacon BR, Camaschella.C. HFE and other hemochromatosis genes. June 2020; Available from: UpToDate.